Dangerous liaisons: doctors-in-training and the pharmaceutical industry.

Abstract:

:Interaction between doctors and the pharmaceutical industry is long-standing and ingrained in modern practice. Doctors-in-training are at a vulnerable stage of their careers, both in requiring knowledge and forming lasting relationships. There is evidence that limiting contact between industry and junior doctors has a positive effect on subsequent clinical behaviour. Currently in Australia, there is no limitation on pharmaceutical representatives approaching doctors-in-training, and the majority of education sessions are sponsored by pharmaceutical companies. This purposefully creates a sense of reciprocity, which may have adverse long-term consequences on attitudes, behaviours and patient care. Several guidelines exist that may assist junior doctors in navigating these potential interactions, most notably the Royal Australasian College of Physicians' own Guidelines for Ethical Relationships between Physicians and Industry. Despite this, there is no reflection of its importance or necessity within subspecialty curricula. This should be rectified, to the benefit of both the profession and public.

journal_name

Intern Med J

authors

Pokorny AM,Gittins CB

doi

10.1111/imj.12855

subject

Has Abstract

pub_date

2015-10-01 00:00:00

pages

1085-8

issue

10

eissn

1444-0903

issn

1445-5994

journal_volume

45

pub_type

杂志文章
  • Trends in practice: attitudes and challenges in the diagnosis, treatment and management of HIV infection in Australia.

    abstract::As life expectancy for people living with human immunodeficiency virus (HIV) (PLWHIV) increases, management models for HIV infection are changing. To understand approaches to practice within this shifting climate and across different medical settings, in 2017 we conducted a baseline survey among the main medical pract...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.15129

    authors: Smith DE,Woolley IJ,Russell DB,Bisshop F,Furner V

    更新日期:2020-12-01 00:00:00

  • Pharmaceutical Benefits Scheme criteria for the use of tumour necrosis factor-alpha inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?

    abstract:BACKGROUND:In 2004, the Pharmaceutical Benefits Scheme (PBS) listed infliximab as a subsidised treatment for ankylosing spondylitis (AS). Eligibility to receive this treatment for AS involved fulfilling several criteria. AIM:To examine the medical literature concerning response to tumor necrosis factor (TNF)-alpha inh...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,评审

    doi:10.1111/j.1445-5994.2006.01004.x

    authors: Smith MD,Ahern MJ

    更新日期:2006-02-01 00:00:00

  • Do we need cardiac arrest centres in Australia?

    abstract::The mortality rate post admission to hospital after successful resuscitation from out-of-hospital cardiac arrest is high, with significant variation between regions and individual institutions. While prehospital factors such as age, bystander cardiopulmonary resuscitation and total cardiac arrest time are known to inf...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/j.1445-5994.2012.02866.x

    authors: Stub D,Bernard S,Smith K,Bray JE,Cameron P,Duffy SJ,Kaye DM

    更新日期:2012-11-01 00:00:00

  • Differential clinical characteristics, management and outcome of delirium among ward compared with intensive care unit patients.

    abstract:BACKGROUND:Delirium is common in hospitalised patients but its epidemiology remains poorly characterised. AIMS:To test the hypothesis that patient demographics, clinical phenotype, management and outcomes of patient with delirium in hospital ward patients differ from intensive care unit (ICU) patients. METHODS:Retros...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.14287

    authors: Canet E,Amjad S,Robbins R,Lewis J,Matalanis M,Jones D,Bellomo R

    更新日期:2019-12-01 00:00:00

  • End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study.

    abstract:BACKGROUND:The association between the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) and mortality in end-stage renal disease (ESRD) patients lacks sufficient evidence. AIM:To investigate the efficacy of ACEI and ARB in ESRD patients. METHODS:This nationwide retrospect...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13971

    authors: Lee HF,See LC,Chan YH,Yeh YH,Wu LS,Liu JR,Tu HT,Wang CL,Kuo CT,Chang SH

    更新日期:2018-09-01 00:00:00

  • Polyserositis: a diagnostic challenge.

    abstract:BACKGROUND:Polyserositis (PS) is the inflammation, with effusion, of different serous membranes. It has been associated with different aetiologies, but the aetiology of PS remains unknown in a high percentage of patients. AIMS:The general objective of this retrospective study was to analyse the aetiology of PS cases s...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13966

    authors: Losada I,González-Moreno J,Roda N,Ventayol L,Borjas Y,Domínguez FJ,Fernández-Baca V,García-Gasalla M,Payeras A

    更新日期:2018-08-01 00:00:00

  • Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.

    abstract:BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) is a common cause of incidental liver test abnormalities. General practitioners (GP) have a key role in identifying people with NAFLD at risk of significant liver disease. Recent specialist guidelines emphasise the use of fibrosis algorithms or serum biomarkers rathe...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13667

    authors: Patel PJ,Banh X,Horsfall LU,Hayward KL,Hossain F,Johnson T,Stuart KA,Brown NN,Saad N,Clouston A,Irvine KM,Russell AW,Valery PC,Williams S,Powell EE

    更新日期:2018-02-01 00:00:00

  • Media reporting of health interventions in New Zealand: a retrospective analysis.

    abstract:AIM:To evaluate New Zealand media articles on their coverage of key issues regarding health interventions and whether it is consistent with available evidence. METHODS:A retrospective analysis was carried out of all articles published in five New Zealand media sources over a 6-week period between 15 October and 26 Nov...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,评审

    doi:10.1111/imj.13936

    authors: Robinson C,Cutfield N,Mottershead J,Sharples K,Richards R,Kingan J,Ledgard C,Liyanage A,McLean J,Nahab F,Stewart F,Strachan S,Tucker K,Zhang Z

    更新日期:2018-08-01 00:00:00

  • Don't forget shared decision-making in the COVID-19 crisis.

    abstract::Mechanical ventilation as a resource is limited and may lead to poor outcomes in at-risk populations. Critical care supports may not be preferred by those at risk of deterioration in the COVID-19 setting. Patient-centred communication and shared decision-making should continue to remain central to clinical practice. ...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.14862

    authors: Simpson N,Milnes S,Steinfort D

    更新日期:2020-06-01 00:00:00

  • Thrombolytic therapy for acute ischaemic stroke: successful implementation in an Australian tertiary hospital.

    abstract::The use of tissue-type plasminogen activator (t-PA) in ischaemic stroke outside of experienced stroke centres remains controversial. The aim of this study was to present the initial experience with t-PA in patients with ischaemic stroke at an institution with no prior experience in i.v. stroke thrombolysis and to comp...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/j.1445-5994.2006.01127.x

    authors: Bray JE,Coughlan K,Bladin C

    更新日期:2006-08-01 00:00:00

  • Effects of empagliflozin treatment on cardiac function and structure in patients with type 2 diabetes: a cardiac magnetic resonance study.

    abstract:BACKGROUND:The effects of empagliflozin on cardiac structure and function are not known. AIMS:To examine the changes in cardiac structure and function following the addition of empagliflozin in patients with type 2 (T2D) diabetes using cardiac magnetic resonance (CMR) imaging. METHODS:Twenty patients attending a spec...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.14260

    authors: Cohen ND,Gutman SJ,Briganti EM,Taylor AJ

    更新日期:2019-08-01 00:00:00

  • Predictive value of symptoms, signs and biomarkers on computed tomography pulmonary angiogram results.

    abstract:BACKGROUND:Pulmonary embolism (PE) is associated with significant morbidity and mortality. PE is a heterogeneous entity that causes a wide variety of clinical presentations, making it imperative to establish which clinical symptoms, signs and biomarkers can influence the pretest probability of PE to aid clinicians and ...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13596

    authors: Sethwala A,Wang X,Sturm EE,Collins KL,O'Donnabhain R,Friedman ND

    更新日期:2018-01-01 00:00:00

  • Spectrum of illness among returned Australian travellers from Bali, Indonesia: a 5-year retrospective observational study.

    abstract:BACKGROUND:Bali, Indonesia, presents significant infectious and non-infectious health risks for Australian travellers. Understanding this spectrum of illnesses has the potential to assist clinicians in evaluating unwell returning travellers and guide provision of pre-travel advice. AIM:To describe the spectrum of illn...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13993

    authors: Sohail A,McGuinness SL,Lightowler R,Leder K,Jomon B,Bain CA,Peleg AY

    更新日期:2019-01-01 00:00:00

  • Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis.

    abstract:BACKGROUND:There is a high risk of developing venous thromboembolism (VTE) following total knee arthroplasty (TKA). Conventional thromboprophylactic agents have limitations, such as route of administration, the need for monitoring, narrow therapeutic windows and interactions. Apixaban is a new oral anticoagulant with t...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13139

    authors: King DA,Pow RE,Dickison DM,Vale PR

    更新日期:2016-09-01 00:00:00

  • CHA2 DS2 VASc score predicts unsuccessful electrical cardioversion in patients with persistent atrial fibrillation.

    abstract:BACKGROUND:Atrial fibrillation (AF) is the most common arrhythmia occurring in 2% of the population. It is known that AF increases morbidity and limits quality of life. The CHA2 DS2 VASc score (congestive heart failure/left ventricular dysfunction, hypertension, age ≥75 (doubled), diabetes, stroke (doubled), vascular d...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13319

    authors: Mlodawska E,Tomaszuk-Kazberuk A,Lopatowska P,Kaminski M,Musial WJ

    更新日期:2017-03-01 00:00:00

  • Circuit breakers for addiction.

    abstract::The phenomenon of addiction is complex, although its expression clinically is relatively straightforward. There is a series of neurophysiological changes that mediate changes in the mesolimbic and mesocortical systems which in turn lead to disturbances in reward mechanisms. These then act to perpetuate the cycle of in...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/j.1445-5994.2007.01350.x

    authors: Foy A

    更新日期:2007-05-01 00:00:00

  • Management of neutropenic fever in a private hospital oncology unit.

    abstract:BACKGROUND:Neutropenic fever is a medical emergency, which poses a significant morbidity and mortality risk to cancer patients receiving chemotherapy. National guidelines recommend that patients presenting with suspected neutropenic fever receive appropriate intravenous antibiotics within 60 min of admission. AIM:We a...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.14464

    authors: Skiba R,Sikotra N,Ball T,Arellano A,Gabbay E,Clay TD

    更新日期:2020-08-01 00:00:00

  • Food allergy: is prevalence increasing?

    abstract::It is generally accepted that the prevalence of food allergy has been increasing in recent decades, particularly in westernised countries, yet high-quality evidence that is based on challenge confirmed diagnosis of food allergy to support this assumption is lacking because of the high cost and potential risks associat...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13362

    authors: Tang ML,Mullins RJ

    更新日期:2017-03-01 00:00:00

  • Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis.

    abstract:BACKGROUND:Eosinophilic esophagitis (EoE) is a newly recognised condition that is apparently increasing in prevalence, and the aetiology is poorly understood. The role of aeroallergens in EoE is controversial, given the success of dietary therapy. Massive aeroallergen exposure leading to food bolus obstruction events (...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,多中心研究

    doi:10.1111/imj.12790

    authors: Philpott HL,Nandurkar S,Thien F,Bloom S,Lin E,Goldberg R,Boyapati R,Finch A,Royce SG,Gibson PR

    更新日期:2015-09-01 00:00:00

  • De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer.

    abstract::In Australia, mutations in epidermal growth factor mutations (EGFR) occur in 15% of patients diagnosed with non-small-cell lung cancer and are found with higher frequency in female, non-smokers of Asian ethnicity. Activating mutations in the EGFR gene are rarely described in SCLC. We present two cases of de novo EGFR ...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13531

    authors: Thai A,Chia PL,Russell PA,Do H,Dobrovic A,Mitchell P,John T

    更新日期:2017-09-01 00:00:00

  • Are external management consultancies effective in healthcare improvement, do they reflect value for money and what are the alternative models?

    abstract::Despite the increasing use and costs associated with external management consultancy for healthcare improvement, there is a paucity of formal evaluations examining impact. This paper aims to: (i) discuss the potential benefits and disadvantages of external consultancies in addressing complex healthcare challenges and ...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.14634

    authors: Skouteris H,Kirkpatrick I,Currie G,Braithwaite J,Teede H

    更新日期:2019-11-01 00:00:00

  • Individualised medicine: why we need Bayesian dosing.

    abstract::Individualised drug dosing has been shown to improve patient outcomes and reduce adverse drug events. One method of individualised medicine is the Bayesian approach, which uses prior information about how the population responds to therapy, to inform clinicians about how a specific individual is responding to their cu...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,评审

    doi:10.1111/imj.13412

    authors: Donagher J,Martin JH,Barras MA

    更新日期:2017-05-01 00:00:00

  • Ethics and public health.

    abstract::This paper examines the differences between clinical and public health ethics and provides several examples of contemporary public health challenges that pose ethical questions. The relations among ethics, rights and obligations are explored, because public health philosophers propose these as different ways for publi...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,评审

    doi:10.1111/j.1445-5994.2004.00643.x

    authors: Leeder SR

    更新日期:2004-07-01 00:00:00

  • High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.

    abstract:BACKGROUND/AIM:Although induction chemotherapy comprising high-dose cytarabine (HiDAC) in combination with idarubicin and etoposide or 'ICE' for adult acute myeloid leukaemia (AML) produces a complete remission rate of nearly 80%, gastrointestinal toxicity is significant. Omission of etoposide may produce similar clini...

    journal_title:Internal medicine journal

    pub_type: 临床试验,杂志文章,评审

    doi:10.1111/j.1445-5994.2012.02868.x

    authors: Low M,Lee D,Coutsouvelis J,Patil S,Opat S,Walker P,Schwarer A,Salem H,Avery S,Spencer A,Wei A

    更新日期:2013-03-01 00:00:00

  • What is new in lipid-lowering therapies in diabetes?

    abstract::Diabetes can lead to a myriad of microvascular and macrovascular complications - with the leading cause of mortality in diabetes being cardiovascular disease. Low-density lipoprotein cholesterol, along with non-high-density lipoprotein cholesterol and triglycerides are proven, modifiable risk factors for cardiovascula...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,评审

    doi:10.1111/imj.14291

    authors: Cheung YM,O'Brien R,Ekinci EI

    更新日期:2019-12-01 00:00:00

  • Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

    abstract::Waldenström macroglobulinaemia (WM) is an indolent B-cell malignancy characterised by the presence of immunoglobulin M (IgM) paraprotein and bone marrow infiltration by clonal small B lymphocytes, plasmacytoid lymphocytes and plasma cells. The symptoms of WM are protean, often follow an asymptomatic phase and may incl...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.13311

    authors: Talaulikar D,Tam CS,Joshua D,Ho JP,Szer J,Quach H,Spencer A,Harrison S,Mollee P,Roberts AW,Horvath N,Lee C,Zannettino A,Brown R,Augustson B,Jaksic W,Gibson J,Kalff A,Johnston A,Trotman J,Kalro A,Grigoriadis G,

    更新日期:2017-01-01 00:00:00

  • Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia.

    abstract:BACKGROUND:Chronic lymphocytic leukaemia (CLL) frequently responds to chemoimmunotherapy combining cytotoxic chemotherapy and monoclonal antibodies. However, CLL is associated with significant genetic heterogeneity, and some high-risk forms are known to be chemo-resistant and associated with early relapse. AIMS:To rev...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,评审

    doi:10.1111/imj.13680

    authors: Kuss BJ,Tam CS

    更新日期:2017-12-01 00:00:00

  • Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.

    abstract::This article reports the findings of a survey developed to assess the current use of antifungal prophylaxis among haematology and infectious disease clinicians across Australia and New Zealand, and their alignment with existing consensus guidelines for the use of antifungal agents in the haematology/oncology setting (...

    journal_title:Internal medicine journal

    pub_type: 杂志文章,评审

    doi:10.1111/imj.12594

    authors: van Hal SJ,Gilroy NM,Morrissey CO,Worth LJ,Szer J,Tam CS,Chen SC,Thursky KA,Slavin MA

    更新日期:2014-12-01 00:00:00

  • Marijuana 'bong' smoking and tuberculosis.

    abstract::The incidence of tuberculosis in the non-indigenous Australian population is low. However, in this paper we report on three cases of cavitating disease, which seem to be associated with a common illicit drug habit namely smoking marijuana using a makeshift pipe or bong. There was a total of 34 positive contacts of the...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.12089

    authors: Thu K,Hayes M,Miles S,Tierney L,Foy A

    更新日期:2013-04-01 00:00:00

  • Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania, Australia.

    abstract:BACKGROUND:High inflammatory bowel disease (IBD) rates have been reported in Australasia, but no state-wide studies have yet been performed. AIM:This study estimates the 1-year incidence and point prevalence of IBD in the state of Tasmania, Australia. It also reports clinical outcomes after 12 months of diagnosis in a...

    journal_title:Internal medicine journal

    pub_type: 杂志文章

    doi:10.1111/imj.14111

    authors: Bhatia R,Yeoh SW,Vaz K,Studd C,Wilson J,Bell S,Otahal P,Venn A

    更新日期:2019-05-01 00:00:00